SELLAS Life Sciences Group, Inc.
Company Stats
- Market Cap
- $2.5B
- as of Sep 30, 2026
- Shares Outstanding
- 201.9M
- Free Float
- 98.2%
Income Statement
- Operating Income
- -$28.3M
- Net Income
- -$26.9M
Balance Sheet
- Cash & Equivalents
- $71.8M
Returns & Capital
- SBC, 3Y Avg
- $1.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2023 | $0 | — | — |
| FY2022 | $1.0M | — | — |
| FY2021 | $7.6M | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges